Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Autoimmune Disorders

Free Subscription Articles published in J Rheumatol Retrieve available abstracts of 133 articles: HTML format

Single Articles

December 2025
1. ALY S, Parastandehchehr G, Bernatsky S, Vinet E, et al
   A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.
   J Rheumatol. 2025 Dec 1:jrheum.2025-0757. doi: 10.3899/jrheum.2025-0757.
   PubMed     Abstract available
   
   
   
2. DAVIS NA, Wang J, Wang X, Getachew LS, et al
   Investigating factors associated with respiratory syncytial virus vaccination and breakthrough infection among patients with systemic autoimmune rheumatic diseases.
   J Rheumatol. 2025 Dec 1:jrheum.2025-0934. doi: 10.3899/jrheum.2025-0934.
   PubMed     Abstract available
   
   
   November 2025
3. O'CONNOR SK, Devarajan P, Liu J, Maldonado MA, et al
   The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients with Lupus Nephritis.
   J Rheumatol. 2025 Nov 15:jrheum.2025-0504. doi: 10.3899/jrheum.2025-0504.
   PubMed     Abstract available
   
   
   
4. PATEL H, Stoots S, Von Feldt J, Baker JF, et al
   Performance of Risk Score Calculators in the Identification of Coronary Artery Calcification in Patients with Systemic Lupus Erythematosus.
   J Rheumatol. 2025 Nov 15:jrheum.2025-0465. doi: 10.3899/jrheum.2025-0465.
   PubMed     Abstract available
   
   
   
5. PARPERIS K, Bertsias G, Lampi M, Constantinou M, et al
   Time trends in acute coronary syndrome hospitalizations and outcomes in patients with Systemic Lupus Erythematosus: A US inpatient cohort analysis.
   J Rheumatol. 2025 Nov 15:jrheum.2025-0627. doi: 10.3899/jrheum.2025-0627.
   PubMed     Abstract available
   
   
   
6. QI W, Yuen SY, Popescu ML, Yang R, et al
   The Burden of Enthesitis, Inflammatory Arthritis and Tenosynovitis on Musculoskeletal Ultrasound in Systemic Lupus Erythematous: A Scoping Review.
   J Rheumatol. 2025 Nov 15:jrheum.2025-0684. doi: 10.3899/jrheum.2025-0684.
   PubMed     Abstract available
   
   
   
7. MAYO-JUANATEY A, Castaneda S, Calvo-Rio V, Garijo-Bufort M, et al
   Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.
   J Rheumatol. 2025 Nov 5:jrheum.2025-0658.C1. doi: 10.3899/jrheum.2025-0658.
   PubMed     Abstract available
   
   
   
8. CHAN YN, Ardalan K, Lin L, Chen D, et al
   Congruence Between Child Self-Reported and Caregiver-Proxy Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus.
   J Rheumatol. 2025 Nov 1:jrheum.2025-0598. doi: 10.3899/jrheum.2025-0598.
   PubMed     Abstract available
   
   
   
9. CARLI L, Cavagna L, Cardelli C, Fattorini F, et al
   Anifrolumab therapy in Dermatomyositis: new insights from refractory patients.
   J Rheumatol. 2025 Nov 1:jrheum.2025-0773. doi: 10.3899/jrheum.2025-0773.
   PubMed     Abstract available
   
   
   
10. BARONAITE HANSEN R, Faurschou M, Jacobsen S
    Comorbidity Development and Mortality During 10 Years of Follow-up in Danish Nationwide Cohort of 3,178 Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Nov 1:jrheum.2025-0015. doi: 10.3899/jrheum.2025-0015.
    PubMed     Abstract available
    
    
    
11. KILBAS G, Ayduran S, Sener S, Coskuner T, et al
    Results of a Nationwide Multicenter Study in Childhood Sjogren Disease.
    J Rheumatol. 2025;52:1141-1150.
    PubMed     Abstract available
    
    
    
12. FLATMAN LK, Bernatsky S, Berard A, Vinet E, et al
    Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample.
    J Rheumatol. 2025;52:1159-1165.
    PubMed     Abstract available
    
    
    October 2025
13. OGBONNAYA SA, Williams S, Lightbourne M, Brown RJ, et al
    Type B Insulin Resistance: A Case Report of a Rare Complication of Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Oct 15:jrheum.2025-0533. doi: 10.3899/jrheum.2025-0533.
    PubMed    
    
    
    
14. SRINIVASALU H, Beukelman T, Dennos A, Chen A, et al
    Juvenile Psoriatic Arthritis Inception Cohort in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Characteristics and Early Disease Outcomes.
    J Rheumatol. 2025;52:1013-1020.
    PubMed     Abstract available
    
    
    
15. PONGTARAKULPANIT N, Bishnoi A, Chandra T, Dzanko S, et al
    Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-based Approach.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0537. doi: 10.3899/jrheum.2025-0537.
    PubMed     Abstract available
    
    
    
16. LOPEZ-MARTINEZ J, Esplugues Clos J, Fernandez-Valmana A, Feijoo-Masso C, et al
    Renal AA Amyloidosis Associated With Systemic Lupus Erythematosus Treated With Anakinra.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0431. doi: 10.3899/jrheum.2025-0431.
    PubMed    
    
    
    
17. MAYO-JUANATEY A, Castaneda S, Calvo-Rio V, Garijo-Bufort M, et al
    Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0658. doi: 10.3899/jrheum.2025-0658.
    PubMed    
    
    
    
18. RUBINSTEIN TB, Touma Z, Blanco I, Knight AM, et al
    Improving Mental Health Care for People With Systemic Lupus Erythematosus: Time to Take Action.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0922. doi: 10.3899/jrheum.2025-0922.
    PubMed    
    
    
    September 2025
19. SINGH JA, Beasley M
    Patient Resilience is associated with Better Patient-Reported Physical and Mental/Emotional Quality of Life in Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 15:jrheum.2025-0396. doi: 10.3899/jrheum.2025-0396.
    PubMed     Abstract available
    
    
    
20. YAU E, Chim T, Lim M, Inman RD, et al
    Anti-Integrin alphavbeta6 Autoantibodies as a Biomarker for Ulcerative Colitis in Patients With Axial Spondyloarthritis.
    J Rheumatol. 2025 Sep 15:jrheum.2024-1296. doi: 10.3899/jrheum.2024-1296.
    PubMed     Abstract available
    
    
    
21. YE C, Nikolic RPA, Choi M, Fifi-Mah AV, et al
    Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisti
    J Rheumatol. 2025 Sep 15:jrheum.2025-0482. doi: 10.3899/jrheum.2025-0482.
    PubMed     Abstract available
    
    
    
22. CONSOLARO A, Ruperto N, Lovell DJ, Synoverska O, et al
    Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial.
    J Rheumatol. 2025;52:919-926.
    PubMed     Abstract available
    
    
    
23. JUNEK ML, Chanchlani R, Rodriguez AR, Khalidi N, et al
    Assessment of giant cell arteritis-associated visual outcomes at a tertiary hospital in Ontario, Canada.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0459. doi: 10.3899/jrheum.2025-0459.
    PubMed     Abstract available
    
    
    
24. ZAFFINO I, Boulard L, Law J, Danguecan A, et al
    Individual and Socio-ecological Resilience in Childhood-Onset Systemic Lupus Erythematosus: Associations with Patient Characteristics and Psychosocial Patient-Reported Outcomes.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0375. doi: 10.3899/jrheum.2025-0375.
    PubMed     Abstract available
    
    
    
25. LIN CH, Lin YP
    Classic Magnetic Resonance Imaging Features Unmask Progressive Multifocal Leukoencephalopathy in Rituximab-Treated Neuropsychiatric Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0410. doi: 10.3899/jrheum.2025-0410.
    PubMed    
    
    
    
26. HORN KW, Breneman A, Djavid AR, Boneparth AD, et al
    A Rare and Severe Cutaneous Presentation of Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0367. doi: 10.3899/jrheum.2025-0367.
    PubMed    
    
    
    August 2025
27. PEDERSEN MJ, Host C, Hansen SN, Klotsche J, et al
    School Absence Among Children With Juvenile Idiopathic Arthritis: A National Matched Comparison Study.
    J Rheumatol. 2025;52:801-809.
    PubMed     Abstract available
    
    
    
28. ZIEMBA YC, Elkin EP, Kazemian E, Wilson BM, et al
    COVID-19 vaccine booster uptake and effectiveness among persons with systemic autoimmune and rheumatic diseases.
    J Rheumatol. 2025 Aug 1:jrheum.2025-0535. doi: 10.3899/jrheum.2025-0535.
    PubMed     Abstract available
    
    
    July 2025
29. EL TAL T, Steiman A, Knight A, Hiraki LT, et al
    A Pediatric-Adult Provider Dyad Care Model Improves Transition From Pediatric to Adult Healthcare For Youth with Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0046. doi: 10.3899/jrheum.2025-0046.
    PubMed     Abstract available
    
    
    
30. BRUNI C, Elhai M, Distler O
    Personalizing Management of Systemic Sclerosis-Associated Interstitial Lung Disease: Are Autoantibodies the Key for Risk Stratification?
    J Rheumatol. 2025 Jul 15:jrheum.2025-0692. doi: 10.3899/jrheum.2025-0692.
    PubMed    
    
    
    
31. PATEL H, DeMasters D, Tofferi J
    Antinuclear Antibody Multiplex Utilization Across a Large Federal Hospital System: An Investigation of Ordering Practices and Rheumatologic Outcomes.
    J Rheumatol. 2025;52:721-727.
    PubMed     Abstract available
    
    
    
32. KHAROUF F, Mehta P, Alhadri A, Li Q, et al
    Comparative Analysis of Damage Accrual in Lupus Nephritis Stratified by Biological Sex.
    J Rheumatol. 2025 Jul 1:jrheum.2025-0302. doi: 10.3899/jrheum.2025-0302.
    PubMed     Abstract available
    
    
    
33. KHAROUF F, Mehta P, Li Q, Gladman DD, et al
    Comparison of Lupus Nephritis Onset Before and After Age 50: Impact on Presentation and Outcomes in an Inception Cohort.
    J Rheumatol. 2025 Jul 1:jrheum.2024-1278. doi: 10.3899/jrheum.2024-1278.
    PubMed     Abstract available
    
    
    
34. TEAW S, Shojaee A, Carnaru M, Hinchcliff M, et al
    The Risk and Time Course for Autoimmune Rheumatic Disease Development in Patients With Raynaud Phenomenon.
    J Rheumatol. 2025 Jul 1:jrheum.2024-0954. doi: 10.3899/jrheum.2024-0954.
    PubMed    
    
    
    
35. COHEN-HAGAI K, Saban M, Benchetrit S, Bar-Ziv D, et al
    Prevalence, Risk Factors, and Outcomes of Chronic Kidney Disease in Systemic Lupus Erythematosus Patients with and without Lupus Nephritis.
    J Rheumatol. 2025 Jul 1:jrheum.2024-1087. doi: 10.3899/jrheum.2024-1087.
    PubMed     Abstract available
    
    
    
36. JUNEK ML, Okaj I, Patel S, Hu A, et al
    Multivariable models to predict a diagnosis of Giant Cell Arteritis: systematic review and meta-analysis.
    J Rheumatol. 2025 Jul 1:jrheum.2022-1204. doi: 10.3899/jrheum.2022-1204.
    PubMed     Abstract available
    
    
    
37. SMITH JD, Pan B, Keeling S
    Identifying the State of Mental Health Care in Canadian Adults with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Jul 1:jrheum.2025-0089. doi: 10.3899/jrheum.2025-0089.
    PubMed     Abstract available
    
    
    May 2025
38. GUNGORER V, Celik IK, Artac H, Celikel Acar B, et al
    OTULIN-Related Autoinflammatory Syndrome With a Novel Mutation Treated With Tumor Necrosis Factor Inhibitor Therapy: A Rare Case Report.
    J Rheumatol. 2025 May 15:jrheum.2024-1141. doi: 10.3899/jrheum.2024-1141.
    PubMed    
    
    
    
39. PIRES DA ROSA G, Granja BV, Azevedo F, Magina S, et al
    Pyoderma Gangrenosum-Associated Autoinflammatory Syndrome With Skin Abscesses: Successful Treatment With Anti-Interleukin 1 Therapy.
    J Rheumatol. 2025 May 15:jrheum.2025-0036. doi: 10.3899/jrheum.2025-0036.
    PubMed    
    
    
    
40. RODRIGUEZ-REYNA TS
    The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease.
    J Rheumatol. 2025 May 15:jrheum.2025-0463. doi: 10.3899/jrheum.2025-0463.
    PubMed    
    
    
    
41. JIANG Z, Barra L
    Does Prior Authorization for Tocilizumab Lead to Unacceptable Treatment Delays in Giant Cell Arteritis?
    J Rheumatol. 2025 May 15:jrheum.2025-0423. doi: 10.3899/jrheum.2025-0423.
    PubMed    
    
    
    
42. PLANTINGA LC, Roberts ET, Hoge C, Pearce BD, et al
    Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus.
    J Rheumatol. 2025;52:479-488.
    PubMed     Abstract available
    
    
    
43. PATTERSON SL, Ruvalcaba D, Issa A, Rai K, et al
    Experiences with Complementary and Integrative Health Among People with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Qualitative Study.
    J Rheumatol. 2025 May 1:jrheum.2024-1218. doi: 10.3899/jrheum.2024-1218.
    PubMed     Abstract available
    
    
    
44. KIM H
    Interferon Response Gene Score in Juvenile Dermatomyositis.
    J Rheumatol. 2025 May 1:jrheum.2025-0395. doi: 10.3899/jrheum.2025-0395.
    PubMed    
    
    
    March 2025
45. FETERMAN JIMENEZ D, Thomason JL, Liew JW, Ferguson S, et al
    Delays in Tocilizumab Therapy for Patients With Giant Cell Arteritis in the United States.
    J Rheumatol. 2025 Mar 15:jrheum.2024-0988. doi: 10.3899/jrheum.2024-0988.
    PubMed     Abstract available
    
    
    
46. ICHIKAWA T, Kishida D, Shimojima Y, Yajima N, et al
    Trust in Health Information Sources Among Patients with Systemic Lupus Erythematosus in the Social Networking Era: The TRUMP(2)-SLE Study.
    J Rheumatol. 2025 Mar 15:jrheum.2024-1088. doi: 10.3899/jrheum.2024-1088.
    PubMed     Abstract available
    
    
    
47. MACMAHON J, Massumi M, Duong TT, Garrett RH, et al
    Interferon Response Gene Score in Juvenile Dermatomyositis Correlates Strongly with Disease Activity.
    J Rheumatol. 2025 Mar 15:jrheum.2024-0806. doi: 10.3899/jrheum.2024-0806.
    PubMed     Abstract available
    
    
    
48. GENER KR, Simakova E, Handal M
    Concurrent IgG4-Related Disease and Giant Cell Arteritis: A Rare Case Study.
    J Rheumatol. 2025 Mar 1:jrheum.2024-0861. doi: 10.3899/jrheum.2024-0861.
    PubMed    
    
    
    
49. AGUILA T, Madan R, Palmer MB, Derk CT, et al
    Zebra Bodies in Kidney Biopsy: Drug-Induced Phospholipidosis in a Patient With Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Mar 1:jrheum.2024-1312. doi: 10.3899/jrheum.2024-1312.
    PubMed    
    
    
    February 2025
50. HIGHLAND KB, Chakravarty R, Georgi S, Han M, et al
    Patient Perspectives and Clinical Insights Into the Diagnostic Journey From Connective Tissue Disease to Pulmonary Arterial Hypertension.
    J Rheumatol. 2025 Feb 20:jrheum.2024-0613. doi: 10.3899/jrheum.2024-0613.
    PubMed    
    
    
    
51. AFLAKI M, Bargman JM
    Urine Protein Tests in Systematic Lupus Erythematosus: What Do They Mean?
    J Rheumatol. 2025 Feb 15:jrheum.2024-0910. doi: 10.3899/jrheum.2024-0910.
    PubMed     Abstract available
    
    
    
52. STOUSTRUP P, Kellenberger CJ, Host C, Kuseler A, et al
    Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2025;52:173-180.
    PubMed     Abstract available
    
    
    
53. MUMTAZ S, Koster MJ, Warrington KJ
    Novel Photon-Counting Computed Tomography for the Evaluation of Large-Vessel Giant Cell Arteritis.
    J Rheumatol. 2025 Feb 1:jrheum.2024-1156. doi: 10.3899/jrheum.2024-1156.
    PubMed    
    
    
    
54. NISHAT F, Golding M, Merrill K, Protudjer JLP, et al
    Lived Education Experience of Young Adults with Childhood- and Adult-onset Systemic Lupus Erythematosus: A Multi-Centre Canadian Qualitative Study.
    J Rheumatol. 2025 Feb 1:jrheum.2024-0695. doi: 10.3899/jrheum.2024-0695.
    PubMed     Abstract available
    
    
    
55. ABEL G, Ansari MQ, Snyder MR, Tebo AE, et al
    Historical Perspective on Antinuclear Antibody Testing.
    J Rheumatol. 2025 Feb 1:jrheum.2023-1121. doi: 10.3899/jrheum.2023-1121.
    PubMed     Abstract available
    
    
    December 2024
56. GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I
    Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events.
    J Rheumatol. 2024 Dec 15:jrheum.2024-1204. doi: 10.3899/jrheum.2024-1204.
    PubMed    
    
    
    
57. HASLAK F, Kilic H, Sahin S, Hotaman B, et al
    Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient Cohort.
    J Rheumatol. 2024;51:1208-1217.
    PubMed     Abstract available
    
    
    
58. MAILLE M, Tounkara BS, Vagner D, Bagny K, et al
    Epidemiology of isolated Cutaneous Lupus Erythematosus in the multiethnic population of Reunion Island (France): a retrospective multicentric study.
    J Rheumatol. 2024 Dec 1:jrheum.2024-0661. doi: 10.3899/jrheum.2024-0661.
    PubMed     Abstract available
    
    
    November 2024
59. NAGASE FN, Fukui S, Takizawa N, Yamaguchi T, et al
    Tocilizumab for Giant Cell Arteritis: Clinical Outcomes Following Relapses and Tocilizumab Discontinuation Due to Adverse Events.
    J Rheumatol. 2024 Nov 15:jrheum.2024-0612. doi: 10.3899/jrheum.2024-0612.
    PubMed     Abstract available
    
    
    
60. PARIMI VP, Ravindran V
    Cardiovascular Health and Adverse Pregnancy Outcomes in Autoimmune Rheumatic Diseases.
    J Rheumatol. 2024 Nov 15:jrheum.2024-0828. doi: 10.3899/jrheum.2024-0828.
    PubMed    
    
    
    
61. RANDELL RL, Reeve BB, Weitzman ER, von Scheven E, et al
    Pain Interference in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2024;51:1119-1124.
    PubMed     Abstract available
    
    
    
62. IMAI Y, Ota Y, Matsumoto K, Akiyama M, et al
    Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the European Medicines Agency Algorithm in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    J Rheumatol. 2024;51:1102-1110.
    PubMed     Abstract available
    
    
    
63. BRUNNER HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, et al
    Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.
    J Rheumatol. 2024;51:1125-1134.
    PubMed     Abstract available
    
    
    
64. LIEBER SB, Young SR, Shea Y, Gottesman SP, et al
    The Lived Experiences of Older Adults with Systemic Lupus Erythematosus: Patient Perspectives.
    J Rheumatol. 2024 Nov 1:jrheum.2024-0478. doi: 10.3899/jrheum.2024-0478.
    PubMed     Abstract available
    
    
    
65. ARDALAN K, Rider LG
    Ringing in the Patient Voice: Measuring Patients' Lived Experience of Dermatomyositis Symptoms.
    J Rheumatol. 2024 Nov 1:jrheum.2024-0951. doi: 10.3899/jrheum.2024-0951.
    PubMed     Abstract available
    
    
    
66. JIANG Y, Duarte-Garcia A, Putman M, Gazeley D, et al
    Incidence of Pneumocystis jirovecii Pneumonia and Prophylaxis-Associated Adverse Events Among Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Nov 1:jrheum.2023-1038. doi: 10.3899/jrheum.2023-1038.
    PubMed     Abstract available
    
    
    October 2024
67. LIU X, Zhang J, Xu H, Kuang W, et al
    Epidemiological characteristics of patients with juvenile dermatomyositis in China: a multicenter study.
    J Rheumatol. 2024 Oct 15:jrheum.2024-0003. doi: 10.3899/jrheum.2024-0003.
    PubMed     Abstract available
    
    
    
68. ZAREK J, Lee J, Harakati D, Spitzer K, et al
    Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review.
    J Rheumatol. 2024;51:964-972.
    PubMed     Abstract available
    
    
    
69. OCAMPO-TORRES MC, Hernandez-Molina G, Criales-Vera S, Sanchez-Guerrero J, et al
    Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus.
    J Rheumatol. 2024;51:991-996.
    PubMed     Abstract available
    
    
    
70. NIETO RE, Alarcon GS, Arnaud L, Pons-Estel GJ, et al
    Finding the Role of Anifrolumab in the New Paradigm of Systemic Lupus Erythematosus Treatment.
    J Rheumatol. 2024 Oct 1:jrheum.2024-0900. doi: 10.3899/jrheum.2024-0900.
    PubMed     Abstract available
    
    
    September 2024
71. VYZHGA Y, Doria AS, Feldman BM, Tse SM, et al
    Mining for Gems: Early Detection of Calcinosis in Juvenile Dermatomyositis Using Low-Dose Computed Tomography.
    J Rheumatol. 2024 Sep 15:jrheum.2024-0594. doi: 10.3899/jrheum.2024-0594.
    PubMed     Abstract available
    
    
    
72. KUWANA M, Wakasugi N, Hashida T, Uno S, et al
    Update on Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: 3-Year Postmarketing Surveillance Follow-Up in Japan.
    J Rheumatol. 2024 Sep 15:jrheum.2024-0379. doi: 10.3899/jrheum.2024-0379.
    PubMed     Abstract available
    
    
    
73. AN J, Marwaha A, Laxer RM
    Autoinflammatory Diseases: A Review.
    J Rheumatol. 2024;51:848-861.
    PubMed     Abstract available
    
    
    August 2024
74. AIRES BP, Wobma H, Samad A, Chandler MT, et al
    Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease.
    J Rheumatol. 2024;51:811-817.
    PubMed     Abstract available
    
    
    
75. KARABUKAYEVA A, Hearld LR, Choi S, Singh JA, et al
    Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations.
    J Rheumatol. 2024;51:798-803.
    PubMed     Abstract available
    
    
    
76. PEDERSEN MJ, Host C, Hansen SN, Klotsche J, et al
    School Well-Being and Academic Performance of Children With Juvenile Idiopathic Arthritis: A National Register-Based Study.
    J Rheumatol. 2024;51:804-810.
    PubMed     Abstract available
    
    
    
77. GOLDER V, Kandane-Rathnayake R, Louthrenoo W, Chen YH, et al
    Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.
    J Rheumatol. 2024;51:790-797.
    PubMed     Abstract available
    
    
    
78. OKITA Y, Okamoto M, Fujimoto J, Kumanogoh A, et al
    Pneumocephalus and Cerebral Abscess in Granulomatosis With Polyangiitis.
    J Rheumatol. 2024;51:832.
    PubMed    
    
    
    
79. YAMADA H, Sugiyama T, Ito Y, Toriihara A, et al
    Detection of Pancreatitis and Protein-Losing Gastroenteropathy Associated With Systemic Lupus Erythematosus by Protein Leakage Scintigraphy.
    J Rheumatol. 2024 Aug 1:jrheum.2024-0468. doi: 10.3899/jrheum.2024-0468.
    PubMed     Abstract available
    
    
    
80. CHRISTOPHER-STINE L, Ciesluk A, Chinoy H, Goyal NA, et al
    The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms.
    J Rheumatol. 2024 Aug 1:jrheum.2023-1137. doi: 10.3899/jrheum.2023-1137.
    PubMed     Abstract available
    
    
    
81. GARG S, Plantinga LC
    A Bitter Pill to Swallow: The Challenge of Medication Nonadherence in Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Aug 1:jrheum.2024-0654. doi: 10.3899/jrheum.2024-0654.
    PubMed     Abstract available
    
    
    July 2024
82. BOWDISH DME, Chandran V, Hitchon CA, Kaplan GG, et al
    When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study.
    J Rheumatol. 2024;51:721-727.
    PubMed     Abstract available
    
    
    
83. BAGGETT KH, Brandon TG, Xiao R, Weiss PF, et al
    Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A Case-Control Study.
    J Rheumatol. 2024;51:708-714.
    PubMed     Abstract available
    
    
    
84. TANI C, Cardelli C, Zen M, Moroni L, et al
    Anifrolumab In Refractory Systemic Lupus Erythematosus: A Real-Life, Multicenter Study.
    J Rheumatol. 2024 Jul 1:jrheum.2024-0053. doi: 10.3899/jrheum.2024-0053.
    PubMed     Abstract available
    
    
    
85. TELES MS, Brundage J, Chiang TP, Alejo JL, et al
    Prevalence and Risk Factors of Post-Acute Sequela of COVID-19 in Adults with Systemic Autoimmune Rheumatic Diseases.
    J Rheumatol. 2024 Jul 1:jrheum.2023-1212. doi: 10.3899/jrheum.2023-1212.
    PubMed     Abstract available
    
    
    June 2024
86. UGARTE-GIL MF, Alarcon GS
    Low Disease Activity Early in the Course of Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Jun 15:jrheum.2024-0502. doi: 10.3899/jrheum.2024-0502.
    PubMed     Abstract available
    
    
    
87. DHITAL R, Baer RJ, Bandoli G, Chambers C, et al
    Cardiovascular Events During Pregnancy: Implications for Adverse Pregnancy Outcomes in Individuals With Autoimmune and Rheumatic Diseases.
    J Rheumatol. 2024 Jun 15:jrheum.2024-0306. doi: 10.3899/jrheum.2024-0306.
    PubMed     Abstract available
    
    
    
88. KOBAYASHI H, Yoshida Y, Kida T, Yajima N, et al
    Seasonal Effects on Relapse of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Multicenter Cohort Study in Japan (J-CANVAS).
    J Rheumatol. 2024;51:646-648.
    PubMed    
    
    
    
89. KWOK TSH, Zhou AL, Nguyen EL, Kwan A, et al
    Preliminary Development of a Novel Tool to Document Vessel Wall Involvement in Patients With Large-Vessel Vasculitis.
    J Rheumatol. 2024;51:637-639.
    PubMed    
    
    
    
90. MISZTAL MC, Gold N, Cao J, Diaz T, et al
    Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.
    J Rheumatol. 2024 Jun 1:jrheum.2023-1036. doi: 10.3899/jrheum.2023-1036.
    PubMed     Abstract available
    
    
    
91. SUN K, Molokwu NJ, Hanlen-Rosado E, Corneli AL, et al
    Implementation of a clinician-led medication adherence intervention among patients with systemic lupus erythematosus.
    J Rheumatol. 2024 Jun 1:jrheum.2024-0071. doi: 10.3899/jrheum.2024-0071.
    PubMed     Abstract available
    
    
    May 2024
92. KANIECKI T, Moyers B, Lubinus M, Hu YP, et al
    Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis: An Observational Survey.
    J Rheumatol. 2024 May 15:jrheum.2024-0108. doi: 10.3899/jrheum.2024-0108.
    PubMed     Abstract available
    
    
    
93. AKPOIGBE O, Anim-Koranteng C, Tasmin R, Sammut A, et al
    A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With Gastrointestinal Stromal Tumor.
    J Rheumatol. 2024 May 15:jrheum.2024-0114. doi: 10.3899/jrheum.2024-0114.
    PubMed     Abstract available
    
    
    
94. AVASARALA J, Das S, Keshavamurthy S
    Point-of-Care Ultrasound With Artificial Intelligence-Driven Diagnostics in Giant Cell Arteritis: Blindness Prevention on a Global Scale.
    J Rheumatol. 2024 May 15:jrheum.2024-0217. doi: 10.3899/jrheum.2024-0217.
    PubMed     Abstract available
    
    
    
95. BRIDGES JM, Li J, Mannion ML, Clowse MEB, et al
    Contraception Care Patterns for Adult Females With Juvenile Idiopathic Arthritis on Teratogens in the Rheumatology Informatics System for Effectiveness (RISE) Registry.
    J Rheumatol. 2024;51:542-545.
    PubMed    
    
    
    April 2024
96. SEMALULU T, Berard R, Beattie K, Basodan D, et al
    Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.
    J Rheumatol. 2024;51:403-407.
    PubMed     Abstract available
    
    
    
97. OWN M, Bloostein A, Spiera R, Berman JR, et al
    Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series.
    J Rheumatol. 2024;51:390-395.
    PubMed     Abstract available
    
    
    
98. CONTRERAS MARTIN GN
    Lupus Nephritis Treatment Strategies.
    J Rheumatol. 2024 Apr 1:jrheum.2024-0172. doi: 10.3899/jrheum.2024-0172.
    PubMed     Abstract available
    
    
    
99. JUNEK M, Barra L, Kopp A, Felfeli T, et al
    Phase Specific Health Care Costs Associated with Giant Cell Arteritis in Ontario, Canada.
    J Rheumatol. 2024 Apr 1:jrheum.2023-1245. doi: 10.3899/jrheum.2023-1245.
    PubMed     Abstract available
    
    
    
100. ROBERTS JE, Faino A, Bryan MA, Cogen JD, et al
     Hospitalization and Mortality due to Infection among United States Children and Adolescents with Systemic Lupus Erythematosus.
     J Rheumatol. 2024 Apr 1:jrheum.2023-1219. doi: 10.3899/jrheum.2023-1219.
     PubMed     Abstract available
     
     
     March 2024
101. YAMAMOTO H, Taniguchi Y
     Cranial Giant Cell Arteritis and Subdural Hematoma.
     J Rheumatol. 2024 Mar 15:jrheum.2024-0008. doi: 10.3899/jrheum.2024-0008.
     PubMed     Abstract available
     
     
     
102. YENNEMADI AS, Jordan N, Diong S, Keane J, et al
     The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases.
     J Rheumatol. 2024;51:234-241.
     PubMed     Abstract available
     
     
     
103. FALASINNU T, Nguyen T, Jiang TE, Tamang S, et al
     The Problem of Pain in Rheumatology: Variations in Case Definitions Derived From Chronic Pain Phenotyping Algorithms Using Electronic Health Records.
     J Rheumatol. 2024;51:297-304.
     PubMed     Abstract available
     
     
     
104. YASUDA N, Yamane T
     Leg Gangrene in Granulomatosis With Polyangiitis.
     J Rheumatol. 2024;51:316-317.
     PubMed    
     
     
     
105. PATEL NJ, Wang X, Lin M, Kowalski EN, et al
     Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease.
     J Rheumatol. 2024 Mar 1:jrheum.2023-1092. doi: 10.3899/jrheum.2023-1092.
     PubMed     Abstract available
     
     
     
106. DAWOUD SA, Ahmad NU, Shriver EM, Chung SM, et al
     Orbital and Optic Nerve Sheath Involvement and Pupil-Involving Cranial Nerve 3 Palsy in Giant Cell Arteritis.
     J Rheumatol. 2024 Mar 1:jrheum.2023-1195. doi: 10.3899/jrheum.2023-1195.
     PubMed     Abstract available
     
     
     
107. MORAND EF, Jones SA
     Flare in Systemic Lupus Erythematosus: Lost in Translation?
     J Rheumatol. 2024 Mar 1:jrheum.2024-0122. doi: 10.3899/jrheum.2024-0122.
     PubMed     Abstract available
     
     
     February 2024
108. TAKEUCHI T, Wakasugi N, Hashida T, Uno S, et al
     Long-term safety and effectiveness of tacrolimus in patients with lupus nephritis in Japan: 10-year analysis of the real-world TRUST study.
     J Rheumatol. 2024 Feb 15:jrheum.2023-0210. doi: 10.3899/jrheum.2023-0210.
     PubMed     Abstract available
     
     
     
109. WALSH M, Strouse J, Bettendorf B
     Paget Disease as a Rare Mimicker of Giant Cell Arteritis.
     J Rheumatol. 2024 Feb 15:jrheum.2023-1160. doi: 10.3899/jrheum.2023-1160.
     PubMed     Abstract available
     
     
     
110. SAGY I, Schwarzfuchs O, Zeller L, Ling E, et al
     Short- and Long-Term Mortality of Hospitalized Patients with Autoimmune Rheumatic Diseases and Serious Infections: A National Cohort Study.
     J Rheumatol. 2024 Feb 1:jrheum.2023-1063. doi: 10.3899/jrheum.2023-1063.
     PubMed     Abstract available
     
     
     
111. ALPERS CE
     Antiphospholipid Antibodies (aPL) and Thrombotic Microangiopathy for the Diagnosis of aPL Nephropathy: You Can't Have One Without the Other.
     J Rheumatol. 2024;51:109-111.
     PubMed    
     
     
     
112. PEDERSEN MJ, Host C, Hansen SN, Deleuran BW, et al
     Psychiatric Morbidity Is Common Among Children With Juvenile Idiopathic Arthritis: A National Matched Cohort Study.
     J Rheumatol. 2024;51:181-188.
     PubMed     Abstract available
     
     
     December 2023
113. ROGERS JL, Clowse MEB, McKenna K, Starling S, et al
     Patient and physician perspectives of systemic lupus erythematosus flare: A qualitative study.
     J Rheumatol. 2023 Dec 15:jrheum.2023-0721. doi: 10.3899/jrheum.2023-0721.
     PubMed     Abstract available
     
     
     
114. SKYDEL JJ, Ramachandran R, Suttiratana S, Ross JS, et al
     Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies.
     J Rheumatol. 2023 Dec 15:jrheum.2023-0920. doi: 10.3899/jrheum.2023-0920.
     PubMed     Abstract available
     
     
     November 2023
115. TOUMA Z, Parodis I, Strand V
     More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus.
     J Rheumatol. 2023 Nov 15:jrheum.2023-0947. doi: 10.3899/jrheum.2023-0947.
     PubMed     Abstract available
     
     
     
116. RUBENSTEIN E, Maldini C, Vaglio A, Bello F, et al
     Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis.
     J Rheumatol. 2023;50:1446-1453.
     PubMed     Abstract available
     
     
     
117. ROZENBLYUM EV, Chan MO, Gakhal NK
     Chew on This: The Afterbite of Temporomandibular Joint Involvement in Adults With Juvenile Idiopathic Arthritis.
     J Rheumatol. 2023;50:1364-1366.
     PubMed    
     
     
     
118. RUPERTO N, Lovell DJ, Berman A, Anton J, et al
     Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials.
     J Rheumatol. 2023;50:1471-1480.
     PubMed     Abstract available
     
     
     
119. DE SONNAVILLE WFC, Speksnijder CM, Zuithoff NPA, Heijstek MW, et al
     Clinically Established Temporomandibular Involvement in Adults With Juvenile Idiopathic Arthritis.
     J Rheumatol. 2023;50:1462-1470.
     PubMed     Abstract available
     
     
     
120. OGURO N, Yajima N, Ishikawa Y, Sakurai N, et al
     Impact of Attending Rheumatologist's Big Five Personality Traits on Systemic Lupus Erythematosus Patients' Trust: The TRUMP2-SLE Project.
     J Rheumatol. 2023 Nov 1:jrheum.2023-0603. doi: 10.3899/jrheum.2023-0603.
     PubMed     Abstract available
     
     
     October 2023
121. SUN YS, Huang DF, Chen WS, Liao HT, et al
     Risk factor and incidence of serious infections in systemic lupus erythematosus patients undergoing rituximab therapy.
     J Rheumatol. 2023 Oct 15:jrheum.2023-0623. doi: 10.3899/jrheum.2023-0623.
     PubMed     Abstract available
     
     
     
122. PARREAU S, Dumonteil S, Gondran G, Bezanahary H, et al
     Frequency and Significance of Hepatic Involvement in New-Onset Giant Cell Arteritis: A Study of 514 Patients.
     J Rheumatol. 2023 Oct 15:jrheum.2023-0358. doi: 10.3899/jrheum.2023-0358.
     PubMed     Abstract available
     
     
     
123. KAWANO Y, Wang X, Patel NJ, Qian G, et al
     Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases.
     J Rheumatol. 2023 Oct 15:jrheum.2023-0742. doi: 10.3899/jrheum.2023-0742.
     PubMed     Abstract available
     
     
     
124. NIETO-GONZALEZ JC, Garulo DC, Boteanu A, Trives-Folguera L, et al
     What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?
     J Rheumatol. 2023;50:1326-1332.
     PubMed     Abstract available
     
     
     
125. AGUIRRE A, DeQuattro K, Shiboski S, Katz P, et al
     Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a Multiethnic Cohort of Patients With Systemic Lupus Erythematosus.
     J Rheumatol. 2023;50:1302-1309.
     PubMed     Abstract available
     
     
     
126. LIU S, Han L, Li M, Tian X, et al
     Sex Differences in Clinical Manifestations of Hospitalized Patients With Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Cohort Study.
     J Rheumatol. 2023;50:1318-1325.
     PubMed     Abstract available
     
     
     
127. QUINTANA R, Ramirez-Flores MF, Fuentes-Silva Y, Pelaez-Ballestas I, et al
     Diagnostic Delay in Autoimmune Rheumatic Diseases: A Global Health Problem.
     J Rheumatol. 2023 Oct 1:jrheum.2023-0847. doi: 10.3899/jrheum.2023-0847.
     PubMed     Abstract available
     
     
     September 2023
128. PESKIN M, Mostowy M, Velez J, Perron M, et al
     Clinical improvement in early onset interstitial lung disease using rituximab in children with anti-MDA5 positive juvenile dermatomyositis.
     J Rheumatol. 2023 Sep 15:jrheum.2023-0544. doi: 10.3899/jrheum.2023-0544.
     PubMed     Abstract available
     
     
     
129. SASAI T, Nakashima R, Tsuji H, Nakajima T, et al
     Long term prognosis of anti-melanoma differentiation-associated gene 5-positive dermatomyositis with interstitial lung disease.
     J Rheumatol. 2023 Sep 15:jrheum.2023-0371. doi: 10.3899/jrheum.2023-0371.
     PubMed     Abstract available
     
     
     
130. YOSHIDA Y, Nakamoto N, Oka N, Kidoguchi G, et al
     Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
     J Rheumatol. 2023;50:1152-1158.
     PubMed     Abstract available
     
     
     
131. WEISS PF, Brandon TG, Lambert RG, Biko DM, et al
     Consensus-Driven Definition for Unequivocal Sacroiliitis on Radiographs in Juvenile Spondyloarthritis.
     J Rheumatol. 2023;50:1173-1177.
     PubMed     Abstract available
     
     
     
132. MOISEEV S, Bulanov N, Crnogorac M, Direskeneli H, et al
     Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study.
     J Rheumatol. 2023;50:1145-1151.
     PubMed     Abstract available
     
     
     
133. FERUCCI ED
     Improving Outcomes in Systemic Lupus Erythematosus: The Importance of Access to Medications.
     J Rheumatol. 2023 Sep 1:jrheum.2023-0772. doi: 10.3899/jrheum.2023-0772.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.